| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-111 |
Sentence |
denotes |
Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies. |
| TextSentencer_T2 |
112-122 |
Sentence |
denotes |
OBJECTIVE: |
| TextSentencer_T3 |
123-265 |
Sentence |
denotes |
Alterations in maternal circulating angiogenic factors are proposed to result in hypertension and proteinuria and development of preeclampsia. |
| TextSentencer_T4 |
266-413 |
Sentence |
denotes |
The aim of this study was to explore whether preeclampsia risk factors are associated with maternal angiogenic profile in normotensive pregnancies. |
| TextSentencer_T5 |
414-427 |
Sentence |
denotes |
STUDY DESIGN: |
| TextSentencer_T6 |
428-794 |
Sentence |
denotes |
Associations of pregnancy characteristics and maternal serum concentrations at delivery of proangiogenic placental growth factor (PlGF), antiangiogenic soluble fms-like tyrosine kinase receptor (sFlt1) and soluble endoglin (sEng), as well as the antiangiogenic ratios sFlt1/PlGF and (sFlt1+sEng)/PlGF were analyzed in 43 normotensive and 44 preeclamptic pregnancies. |
| TextSentencer_T7 |
795-803 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T8 |
804-990 |
Sentence |
denotes |
In normotensive pregnancies, increasing maternal age was associated with a more antiangiogenic profile, including lower PlGF concentrations and a higher (sFlt1+sEng)/PlGF ratio (P<0.05). |
| TextSentencer_T9 |
991-1121 |
Sentence |
denotes |
In preeclampsia, shorter length of gestation and lower birth weight percentile were associated with a more antiangiogenic profile. |
| TextSentencer_T10 |
1122-1133 |
Sentence |
denotes |
CONCLUSION: |
| TextSentencer_T11 |
1134-1271 |
Sentence |
denotes |
A greater antiangiogenic profile with older maternal age may suggest a biological mechanism which mediates this preeclampsia risk factor. |
| TextSentencer_T12 |
1272-1403 |
Sentence |
denotes |
In preeclampsia, the antiangiogenic state was more pronounced with clinical characteristics indicative of greater disease severity. |
| T1 |
0-111 |
Sentence |
denotes |
Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies. |
| T2 |
112-122 |
Sentence |
denotes |
OBJECTIVE: |
| T3 |
123-265 |
Sentence |
denotes |
Alterations in maternal circulating angiogenic factors are proposed to result in hypertension and proteinuria and development of preeclampsia. |
| T4 |
266-413 |
Sentence |
denotes |
The aim of this study was to explore whether preeclampsia risk factors are associated with maternal angiogenic profile in normotensive pregnancies. |
| T5 |
414-427 |
Sentence |
denotes |
STUDY DESIGN: |
| T6 |
428-794 |
Sentence |
denotes |
Associations of pregnancy characteristics and maternal serum concentrations at delivery of proangiogenic placental growth factor (PlGF), antiangiogenic soluble fms-like tyrosine kinase receptor (sFlt1) and soluble endoglin (sEng), as well as the antiangiogenic ratios sFlt1/PlGF and (sFlt1+sEng)/PlGF were analyzed in 43 normotensive and 44 preeclamptic pregnancies. |
| T7 |
795-803 |
Sentence |
denotes |
RESULTS: |
| T8 |
804-990 |
Sentence |
denotes |
In normotensive pregnancies, increasing maternal age was associated with a more antiangiogenic profile, including lower PlGF concentrations and a higher (sFlt1+sEng)/PlGF ratio (P<0.05). |
| T9 |
991-1121 |
Sentence |
denotes |
In preeclampsia, shorter length of gestation and lower birth weight percentile were associated with a more antiangiogenic profile. |
| T10 |
1122-1133 |
Sentence |
denotes |
CONCLUSION: |
| T11 |
1134-1271 |
Sentence |
denotes |
A greater antiangiogenic profile with older maternal age may suggest a biological mechanism which mediates this preeclampsia risk factor. |
| T12 |
1272-1403 |
Sentence |
denotes |
In preeclampsia, the antiangiogenic state was more pronounced with clinical characteristics indicative of greater disease severity. |